[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334831-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334831-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","metabolite-profiling-of-human-renal-cell-carcinoma-reveals-tissue-origin-dominance-in-nutrient-availability","Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability","","The tumor microenvironment shapes cancer progression and therapeutic effectiveness, with nutrient availability serving as a key driver. While it is known that local nutrient abundance governs metabolic behavior during tumor growth, the determinants of nutrient availability in tumor tissue versus matched normal tissue and blood are not well defined. Using quantitative metabolomics and comprehensive lipidomics of tumor interstitial fluid, adjacent normal kidney interstitial fluid, and patient plasma, the study identifies tissue-related control of nutrient levels in renal cell carcinoma.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/metabolite-profiling-of-human-renal-cell-carcinoma-reveals-tissue-origin-dominance-in-nutrient-availability/334831/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/metabolite-profiling-of-human-renal-cell-carcinoma-reveals-tissue-origin-dominance-in-nutrient-availability/334831.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does nutrient availability play in the tumor microenvironment?","Question",{"text":63,"@type":64},"Nutrient availability is a determinant of cancer progression and therapeutic efficacy. It influences metabolic parameters that support tumor growth and responses to treatment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study measure nutrient availability across tumor, normal tissue, and blood?",{"text":68,"@type":64},"It performed quantitative metabolomic and comprehensive lipidomic analyses using tumor interstitial fluid, adjacent normal kidney interstitial fluid, and plasma samples from patients.",{"name":70,"@type":61,"acceptedAnswer":71},"What do the findings suggest about what controls nutrient levels in renal cell carcinoma?",{"text":72,"@type":64},"Tumor interstitial fluid nutrient composition closely resembles adjacent normal kidney interstitial fluid, indicating that tissue-specific factors unrelated to cancer exert stronger influence than tumor-driven alterations.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334831,1790196733,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","SHORT REPORT  \n*For correspondence:  \n[jeff.rathmell@vumc.org](jeff.rathmell@vumc.org) (JR); [mvh@mit.edu](mvh@mit.edu) (MGVH)  \n†These authors contributed equally to this work  \nPresent address: ‡UMass Chan Medical School, Program in Molecular Medicine, Worcester, United States  \nCompeting interest: See page 12  \nFunding: See page 12  \nPreprint posted  \n24 December 2023  \nSent for Review  \n02 January 2024  \nReviewed preprint posted  \n13 February 2024  \nReviewed preprint revised  \n01 May 2024  \nVersion of Record published  \n24 May 2024  \nReviewing Editor: Qing Zhang, The University of Texas Southwestern Medical Center, United States  \n Copyright Abbott, Ali, Reinfeld et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use andredistribution provided that the original author and source are credited.  \nMetabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability  \nKeene L Abbott1,2,3†, Ahmed Ali2,3†, Bradley I Reinfeld4,5,6†, Amy Deik3, Sonu Subudhi7, Madelyn D Landis5, Rachel A Hongo5, Kirsten L Young5,  \nTenzin Kunchok8, Christopher S Nabel2,9,10, Kayla D Crowder8, Johnathan R Kent11, Maria Lucia L Madariaga11, Rakesh K Jain7, Kathryn E Beckermann5,  \nCaroline A Lewis8‡, Clary B Clish3, Alexander Muir12, W Kimryn Rathmell5,13, Jeffrey Rathmell13,14*, Matthew G Vander Heiden1,2,3,15*  \n1 Department of Biology, Massachusetts Institute of Technology, Cambridge, United States; 2 Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, United States; 3 Broad Institute of MIT and Harvard, Cambridge, United States; 4 Medical Scientist Training Program, Vanderbilt University, Nashville, United States; 5 Department of Medicine, Vanderbilt University Medical Center (VUMC), Nashville, United States; 6Graduate Program in Cancer Biology, Vanderbilt University, Nashville, United States; 7Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, United States; 8Whitehead Institute for Biomedical Research, Cambridge, United States; 9 Department of Medicine, Massachusetts General Hospital, Boston, United States; 10 Harvard Medical School, Boston, United States; 11 Department of Surgery, University of Chicago Medicine, Chicago, United States; 12 Ben May Department of Cancer Research, University of Chicago, Chicago, United States; 13Vanderbilt Center for Immunobiology and Vanderbilt-Ingram Cancer Center, VUMC, Nashville, United States; 14 Department of Pathology, Microbiology and Immunology, VUMC, Nashville, United States; 15 Dana-Farber Cancer Institute, Boston, United States  \nAbstract The tumor microenvironment is a determinant of cancer progression and therapeutic efficacy, with nutrient availability playing an important role. Although it is established that the local abundance of specific nutrients defines the metabolic parameters for tumor growth, the factors guiding nutrient availability in tumor compared to normal tissue and blood remain poorly understood. To define these factors in renal cell carcinoma (RCC), we performed quantitative metabolomicand comprehensive lipidomic analyses of tumor interstitial fluid (TIF), adjacent normal kidney interstitial fluid (KIF), and plasma samples collected from patients. TIF nutrient composition closely resembles KIF, suggesting that tissue-specific factors unrelated to the presence of cancer exert a stronger influence on nutrient levels than tumor-driven alterations. Notably, select metabolite changes consistent with known features of RCC metabolism are found in RCC TIF, while glucose levels in TIF are not depleted to levels that are lower than those found in KIF. These findings inform tissue nutrient dynamics in RCC, highlighting a dominant role of non-cancer-driven tissue factors in shaping nutrient availability in these tumors.  \neLife assessment  \nAbbott, Ali, ","cbCaicGRBCuoUggn","https://ap.wps.com/l/cbCaicGRBCuoUggn","pdf",1635449,18,"English","# Abstract\n# Introduction\n## Nutrient availability in the tumor microenvironment\n## Knowledge gaps in nutrient regulation","[{\"question\":\"What role does nutrient availability play in the tumor microenvironment?\",\"answer\":\"Nutrient availability is a determinant of cancer progression and therapeutic efficacy. It influences metabolic parameters that support tumor growth and responses to treatment.\"},{\"question\":\"How did the study measure nutrient availability across tumor, normal tissue, and blood?\",\"answer\":\"It performed quantitative metabolomic and comprehensive lipidomic analyses using tumor interstitial fluid, adjacent normal kidney interstitial fluid, and plasma samples from patients.\"},{\"question\":\"What do the findings suggest about what controls nutrient levels in renal cell carcinoma?\",\"answer\":\"Tumor interstitial fluid nutrient composition closely resembles adjacent normal kidney interstitial fluid, indicating that tissue-specific factors unrelated to cancer exert stronger influence than tumor-driven alterations.\"}]","Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability | PDF",1790008478,45]